{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2016", "item": "https://www.patentleaderboard.com/2016/"}, {"@type": "ListItem", "position": 3, "name": "Fiberglas Canada", "item": "https://www.patentleaderboard.com/2016/company/fiberglas-canada"}, {"@type": "ListItem", "position": 4, "name": "Mark Dockrell", "item": "https://www.patentleaderboard.com/2016/inventor/fl:ma_ln:dockrell-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MD

Mark Dockrell — 1 Patent in 2016

IPIonis Pharmaceuticals: 1 patents #16 of 39Top 45%
Overall (2016): #309,111 of 481,213Top 65%
1 Patents 2016

Issued Patents 2016

Showing 1–1 of 1 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
9487780 Antisense compounds targeting genes associated with fibronectin Susan M. Freier, Frank Rigo, Felicia Heidibrecht 2016-11-08 $84,872,000